The U.S. biotechnology market enters 2026 as the largest global biotech market, with an estimated size of $552.39 billion in 2023, and is projected to grow to $1.24 trillion by 2030.
AI-assisted drug discovery isn’t just science fiction anymore, especially as biotechnology and biopharma firms embrace the AI ...
2026 could be a big year for this company.
Both could reward patient investors down the line.
As the biotech sector continues to evolve, Truist Securities has identified several companies poised for significant developments in 2026. These companies represe ...
Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY) is one of the best upside stocks to invest in right now. On January 30, Bank of America lowered its price target on Alnylam to $462 from $529 while ...
Raise large amounts of capital with an initial public offering, burn cash while navigating clinical trials, then submit a new ...
Wells Fargo’s 2026 biotech outlook identifies a select group of high-conviction SMID-cap names expected to outperform on the strength of major clinical, regulat ...
After a weak first half, the drug and biotech sector regained momentum in the latter part of 2025, setting the stage for a strong year for select stocks. Improved policy clarity following most large ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results